Skip to main content
. 2023 Apr 28;9:141. doi: 10.1038/s41420-023-01427-9

graphic file with name 41420_2023_1427_Figa_HTML.jpg

A hypothetical model shows that MSI2 binds and activates cap-independent translation of MYC, c-JUN mRNA and HCV through MSI2-binding to Internal Ribosome Entry Sites (IRES) resulting in upregulated MYC, c-JUN and viral protein synthesis and subsequent liver oncogenesis. Inhibitor of the interaction between MYC IRES and MSI2 reduces liver hyperplasia, viral mRNA translation and tumor formation.